{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:21:39Z","timestamp":1785799299709,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T00:00:00Z","timestamp":1382400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-491","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T11:01:29Z","timestamp":1382439689000},"source":"Crossref","is-referenced-by-count":1,"title":["FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases"],"prefix":"10.1186","volume":"13","author":[{"given":"Filip YFL","family":"De Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasja F","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost PH","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen J","family":"F\u00fctterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette TA","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,22]]},"reference":[{"key":"4123_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/bjc.1995.254","volume":"71","author":"R de Wit","year":"1995","unstructured":"de Wit R, Stoter G, Sleijfer DT, Kaye SB, de Mulder PH, ten Bokkel Huinink WW, Spaander PJ, de Pauw M, Sylvester R: Four cycles of BEP versus an alternating regimen of PVB and BEP in patients with poorprognosis metastatic testicular non-seminoma; a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J - Cancer. 1995, 71: 1311-1314. 10.1038\/bjc.1995.254. 1195","journal-title":"Br J - Cancer"},{"key":"4123_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/bjc.1998.587","volume":"78","author":"R de Wit","year":"1998","unstructured":"de Wit R, Stoter G, Sleijfer DT, Neijt JP, Ten Bokkel Huinink WW D, Prijck L, Collette L, Sylvester R: Four cycles of BEP vs. four cycles of VIP in patients with intermediate-prognosis metastatic testicular nonseminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J Cancer. 1998, 78: 828-832. 10.1038\/bjc.1998.587.","journal-title":"Br J Cancer"},{"key":"4123_CR3","first-page":"81","volume":"5","author":"BI Sikic","year":"1986","unstructured":"Sikic BI: Biochemical and cellular determinants of bleomycin cytotoxicity. Cancer Surv. 1986, 5: 81-91.","journal-title":"Cancer Surv"},{"key":"4123_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1378\/chest.120.2.617","volume":"120","author":"S Sleijfer","year":"2001","unstructured":"Sleijfer S: Bleomycin-induced pneumonitis. Chest. 2001, 120: 617-624. 10.1378\/chest.120.2.617.","journal-title":"Chest"},{"key":"4123_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1200\/JCO.2011.35.6733","volume":"29","author":"F Carnevale-Schianca","year":"2011","unstructured":"Carnevale-Schianca F, Gallo S, Rota-Scalabrini D, Sangiolo D, Fizzotti M, Caravelli D, Capaldi A, Anselmetti G, Palesandro E, D\u2019Ambrosio L, Coha V, Obert R, Aglietta M, Grignani G: Complete resolution of lifethreatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin\u2019s lymphoma: hope for severe chemotherapy-induced toxicity?. J Clin Oncol. 2011, 29: 691-693. 10.1200\/JCO.2011.35.6733.","journal-title":"J Clin Oncol"},{"key":"4123_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1148\/radiology.156.1.2408293","volume":"156","author":"EA Bellamy","year":"1985","unstructured":"Bellamy EA, Husband JE, Blaquiere RM, Law MR: Bleomycin-related lung damage: CT evidence. Radiology. 1985, 156: 155-158.","journal-title":"Radiology"},{"key":"4123_CR7","unstructured":"de Wit R, Gietema JA, de Reijke TM, Battermann JJ, van den Bergh ACM, van Gils FCJM, de Kaa CA H-v, de Jong IJ, Los M, van Moorselaar RJA, Witjes JA: Testicarcinoom: landelijke richtlijn. http:\/\/www.oncoline.nl\/testiscarcinoom ,"},{"key":"4123_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0006-2952(88)90518-7","volume":"37","author":"AE Filderman","year":"1988","unstructured":"Filderman AE, Genovese LA, Lazo JS: Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochem Pharmacol. 1988, 37: 1111-1116. 10.1016\/0006-2952(88)90518-7.","journal-title":"Biochem Pharmacol"},{"key":"4123_CR9","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.4049\/jimmunol.171.10.5470","volume":"171","author":"F Huaux","year":"2003","unstructured":"Huaux F, Liu T, McGarry B, Ullenbruch M, Xing Z, Phan SH: Eosinophils and T-lymphocytes possess distinct roles in bleomycininduced lung injury and fibrosis. J Immunol. 2003, 171: 5470-5481.","journal-title":"J Immunol"},{"key":"4123_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1248\/bpb.26.959","volume":"26","author":"T Cui","year":"2003","unstructured":"Cui T, Kusunose M, Hamada A, Ono M, Miyamura M, Yoshioka S, Kyotani S, Nishioka Y: Relationship between the eosinophilia of bronchoalveolar lavage fluid (BALF) and the severity of pulmonary fibrosis induced by bleomycin in rats. Biol Pharm Bull. 2003, 26: 959-963. 10.1248\/bpb.26.959.","journal-title":"Biol Pharm Bull"},{"key":"4123_CR11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.00.16595100","volume":"16","author":"E Sato","year":"2000","unstructured":"Sato E, Koyama S, Robbins RA: Bleomycin stimulates lung fibroblast and epithelial cell lines to release eosinophil chemotactic activity. Eur Respir J. 2000, 16: 951-958.","journal-title":"Eur Respir J"},{"key":"4123_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI200420997","volume":"114","author":"RJ Phillips","year":"2004","unstructured":"Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM: Circulating fibrocytes traffic to the lungs in response to CXCL 12 and mediate fibrosis. J Clin Invest. 2004, 114: 438-446.","journal-title":"J Clin Invest"},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.biocel.2009.02.020","volume":"41","author":"B Mehrad","year":"2009","unstructured":"Mehrad B, Burdick MD, Strieter RM: Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol. 2009, 41: 1708-1718. 10.1016\/j.biocel.2009.02.020.","journal-title":"Int J Biochem Cell Biol"},{"key":"4123_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2353\/ajpath.2007.061167","volume":"171","author":"K Pochetuhen","year":"2007","unstructured":"Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP: Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol. 2007, 171: 428-437. 10.2353\/ajpath.2007.061167.","journal-title":"Am J Pathol"},{"key":"4123_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2214\/ajr.161.3.8352109","volume":"161","author":"GB Kim","year":"1993","unstructured":"Kim GB, Kwon JH, Kang DS: Hypereosinophilic syndrome: imaging findings in patients with hepatic involvement. Am J Roentgenol. 1993, 161: 577-580. 10.2214\/ajr.161.3.8352109.","journal-title":"Am J Roentgenol"},{"key":"4123_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2214\/ajr.172.5.10227499","volume":"172","author":"WJ Lee","year":"1999","unstructured":"Lee WJ, Lim HK, Lim JH, Kim SH, Choi SH, Lee SJ: Foci of eosinophilrelated necrosis in the liver: imaging findings and correlation with eosinophilia. Am J Roentgenol. 1999, 172: 1255-1261. 10.2214\/ajr.172.5.10227499.","journal-title":"Am J Roentgenol"},{"key":"4123_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2214\/ajr.184.4.01841085","volume":"184","author":"J Hur","year":"2005","unstructured":"Hur J, Park MS, Yu JS, Lim JS, Hong SW, Kim KW: Focal eosinophilic necrosis versus metastasis in the liver: the usefulness of two-phase dynamic CT. Am J Roentgenol. 2005, 184: 1085-1090. 10.2214\/ajr.184.4.01841085.","journal-title":"Am J Roentgenol"},{"key":"4123_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00261-011-9752-7","volume":"36","author":"YK Kim","year":"2011","unstructured":"Kim YK, Lee YH, Kim CS, Lee MW: Differentiating focal eosinophilic liver disease from hepatic metastases using enhanced and gadoxetic acid-enhanced MRI. Abdom Imaging. 2011, 36: 425-432. 10.1007\/s00261-011-9752-7.","journal-title":"Abdom Imaging"},{"key":"4123_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.24481","volume":"54","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Bj\u00f6rnsson E: The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology. 2011, 54: 931-939. 10.1002\/hep.24481.","journal-title":"Hepatology"},{"key":"4123_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.86.5.723","volume":"86","author":"DA White","year":"1984","unstructured":"White DA, Stover DE: Severe bleomycin-induced pneumonitis Clinical features and response to corticosteroids. Chest. 1984, 86: 723-728. 10.1378\/chest.86.5.723.","journal-title":"Chest"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-491\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:49:34Z","timestamp":1746035374000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-491","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,22]]},"article-number":"491"}}